Table 3.
OR (95% CI) for the association between TFF3 quartile and incident CKD in the ARIC Study
| TFF3, μg/ml |
p trend |
||||
|---|---|---|---|---|---|
| <0.20 | 0.20−0.50 | 0.51−0.96 | >0.97 | ||
| Cases/total, n | 21/58 | 33/68 | 43/79 | 46/81 | |
| Unadjusted | 1.00 (reference) | 1.84(0.80,4.22) | 2.43(1.06,5.53) | 2.77(1.22,6.28) | 0.02 |
| Model la | 1.00 (reference) | 1.91(0.83,4.42) | 2.47(1.08,5.65) | 2.87(1.25,6.55) | 0.01 |
| Model 1 + urinary ACR | 1.00 (reference) | 1.83(0.76,4.40) | 2.66(1.10,6.43) | 2.90(1.20,6.97) | 0.02 |
a
Adjusted for diabetes, systolic blood pressure, antihypertensive medication use, current smoking, BMI, high-density lipoprotein cholesterol, triglycerides, and baseline eGFR.